Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.

× No keyword cloud information.

23 in total

Review 1. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors: David T Teachey
Journal: Curr Opin Pediatr Date: 2012-02 Impact factor: 2.856

2. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.

Authors: Nicolò Compagno; Francesco Cinetto; Gianpietro Semenzato; Carlo Agostini
Journal: Haematologica Date: 2014-03-28 Impact factor: 9.941

Review 3. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors: Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal: Clin Rev Allergy Immunol Date: 2016-02 Impact factor: 8.667

4. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

Authors: Carla Casulo; Jocelyn Maragulia; Andrew D Zelenetz
Journal: Clin Lymphoma Myeloma Leuk Date: 2012-12-29

5. Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.

Authors: John-Paul Westwood; Mari Thomas; Ferras Alwan; Vickie McDonald; Sylvia Benjamin; William A Lester; Gillian C Lowe; Tina Dutt; Quentin A Hill; Marie Scully
Journal: Blood Adv Date: 2017-06-26

6. B cell depletion for autoimmune diseases in paediatric patients.

Authors: Annette F Jansson; Claudia Sengler; Jasmin Kuemmerle-Deschner; Bernd Gruhn; A Birgitta Kranz; Hartwig Lehmann; Daniela Kleinert; Lars Pape; Hermann J Girschick; Ivan Foeldvari; Dieter Haffner; Johannes P Haas; Dagmar Moebius; Dirk Foell; Joachim Peitz; Veit Grote
Journal: Clin Rheumatol Date: 2010-12-01 Impact factor: 2.980

Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.

Review 1. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

2. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.

Review 3. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

4. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

5. Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.

6. B cell depletion for autoimmune diseases in paediatric patients.

Review 7. The long-term impact of rituximab for childhood immune thrombocytopenia.

Review 8. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

9. Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.

Review 10. Rituximab therapy in nephrotic syndrome: implications for patients' management.